Staccato Apomorphine (AZ-009)

apomorphine · Alexza Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Staccato Apomorphine (AZ-009), covering 2025-10-21 to 2025-10-21. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Staccato Apomorphine (AZ-009) in Patients With Parkinson's Disease Experiencing OFF Episodes [Phase 2]

See pricing